(Sharecast News) - Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal.
Penumbra is focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia.

Under the terms of the...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE